In a report issued September 14, the CDC estimates that 20 percent of US adults (50 million) have chronic pain and 8 percent (20 million) have high-impact chronic pain.
Congratulations to the 2018 Future Leader Grant Recipients!
The 2018 Future Leader Grant Recipients have been announced. Join us in congratulating the winners!
FDA Issues Statement on SUPPORT for Patients and Communities Act
FDA commissioner, Dr. Gottlieb, issued a statement on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
Patients at Ohio Hospital Have Surgery Without Opioids
Patients at Akron General in Ohio hospital are getting non-opioid drugs to manage pain before and after operations.
Notice of Intent to Publish an RFA for Tissue Chips to Model Nociception, Addiction, and Overdose
The National Center for Advancing Translational Sciences (NCATS) has released NOT-TR-19-007, a Notice of Intent to Publish a Funding Opportunity Announcement for Tissue Chips to Model Nociception, Addiction, and Overdose.
Clinical Scientist Development Award
The 2019 CSDA competition is now open and accepting pre-proposals. The deadline to submit pre-proposals is November 28, 2018 at 3 pm ET.
CDC Develops New Quality Improvement and Care Coordination Resource
The CDC National Center for Injury Prevention and Control has developed and released Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain.
CDC Awards New Research Grants
Beginning October 1, the U.S. Centers for Disease Control (CDC) Injury Center is providing funds through the Research Grants for the Primary or Secondary Prevention of Opioid Overdose.
FDA Expands REMS Training to Include More Opioids, More Health Care Providers
The FDA approved a new Opioid Analgesic REMS in September that expands on the previous version and now includes IR opioids, and widens the intended audience to include prescribers and non-prescribers alike.
Nonopioid Approaches to Pain: The Hunt Is On
Dr. Maixner, APS President, discusses the importance of researching and discovering new non-addictive chronic pain management therapies.
NIH Isn’t the Only Source for Grant Funding
American Pain Society grant manager, Susan Vogel, shares the benefits of diversifying revenue sources.
NIH Workshop: Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain
NINDS in collaboration with NCI, NIAAA, NIBIB, NIDCR, NIDA, NIGMS, NINR, NCCIH, and OBSSR will be holding a workshop entitled, Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain.
FDA Awards Opioid Analgesic Guidelines Contract
The FDA has awarded a contract to the National Academies of Sciences, Engineering, and Medicine (NASEM) to help advance the development of evidence-based guidelines for appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures.
FDA to Withdraw 2014 Analgesic Guidance Document
The FDA recently announced it plans to withdraw a 2014 guidance document for developing pain medicines in favor of a more focused approach to promote nonopioid drugs.
FDA Publishes Final REMS Guidance
The Food and Drug Administration (FDA) has approved its final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).
CDC’s New Quality Improvement and Care Coordination Resource
The Centers for Disease Control (CDC) National Center for Injury Prevention and Control has developed and released the Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain.
Opioids Package Nears Passage in Congress
According to Robert Saner of the Pain Care Coalition (PCC), the House and Senate leaderships are trying to push an opioids package through before, and not after, the upcoming House recess for the mid-term elections.
